Humira

Humira (adalimumab) is a biological medication used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. It works by blocking tumor necrosis factor-alpha (TNF-α) to reduce inflammation.

Benefits:

• Effectively reduces inflammation in autoimmune conditions.
• Provides long-term symptom relief.
• Available in a convenient prefilled syringe or pen.
• It can slow disease progression in rheumatoid arthritis.

Dosage:

• Typically administered as a subcutaneous injection every 1–2 weeks, as prescribed.
• Dosage varies based on the condition being treated.

Warnings and Precautions:

• Increased risk of infections due to immune system suppression.
• Avoid live vaccines while using Humira.
• Monitor for signs of serious infections, including fever and persistent cough.

Usage Instructions:

• Inject subcutaneously in the thigh or abdomen.
• Alternate injection sites to avoid irritation.
• Do not shake the pen or syringe before use.

Storage Information:

• Store in the refrigerator; do not freeze.
• Allow to reach room temperature before injecting.

Common Side Effects:

• Mild: Injection site reactions, headache, nausea.
• Severe: Increased risk of infections, allergic reactions, and severe liver problems (seek medical attention if needed).